Adenoma-linked barrier defects and microbial products drive IL 23/IL 17 mediated tumour growth
Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL 23/IL 17 mediated tumour growth. Nature http://dx.doi.org/10. 1038/nature11465.
Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin 2, and antibacterial peptides
Frantz, A. L. et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin 2, and antibacterial peptides. Mucosal Immunol. 5, 501-512 (2012).
The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis
Chen, G. Y., Shaw, M. H., Redondo, G. & Nunez, G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68, 10060-10067 (2008).
Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans
Sanapareddy, N. et al. Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J. 6, 1858-1868 (2012).
Family studies in Crohn's disease: New horizons in understanding disease pathogenesis, risk and prevention
Hedin, C. R., Stagg, A. J., Whelan, K. & Lindsay, J. O. Family studies in Crohn's disease: New horizons in understanding disease pathogenesis, risk and prevention. Gut 61, 311-318 (2012).